Outset Medical, Inc.
OM
$19.96
-$0.32-1.58%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 35.45% | 33.58% | 39.50% | 21.78% | 9.16% |
Total Depreciation and Amortization | -11.37% | -2.77% | -5.12% | -2.84% | 5.49% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 42.00% | -35.20% | -34.72% | 24.77% | -6.63% |
Change in Net Operating Assets | 18.65% | -47.60% | -145.10% | -333.42% | -43.55% |
Cash from Operations | 44.10% | 32.54% | 39.50% | -18.31% | -2.58% |
Capital Expenditure | 65.25% | 95.92% | 49.49% | 84.91% | 56.30% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -32.86% | 342.01% | -46.81% | 39.76% | -1,799.30% |
Cash from Investing | -32.27% | 361.70% | -46.74% | 43.41% | -2,333.48% |
Total Debt Issued | 47.72% | -100.00% | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -80.44% | -100.00% | -97.05% | -92.62% | -60.47% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -18.88% | -102.82% | -97.05% | -92.62% | 1,200.17% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -32.35% | 181.66% | -4,924.18% | 28,315.00% | 1.37% |